Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
202.35
USD
+1.09 (+0.54%)
Official Closing Price
Updated: 7:58 PM EST, Jan 21, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Eli Lilly
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
This Gene Therapy Stock Is Ablaze On Eli Lilly's $1.04 Billion Takeover
December 15, 2020
Eli Lilly agreed to buy gene therapy company Prevail Therapeutics for $1.04 billion on Tuesday, sending PRVL stock to a record high. The deal is worth $880 million up front and a CVR.
From
Investor's Business Daily
Why Eli Lilly Stock Jumped Today
December 15, 2020
The big drugmaker upped its guidance for this year and announced a bullish outlook for 2021.
Tags
LLY
Market News
PRVL
From
Motley Fool
Eli Lilly Acquiring Prevail Therapeutics in $880 Million Deal
December 15, 2020
The buyer is also on the hook for a milestone payment that could hit $4 per share.
Tags
PRVL
LLY
Market News
From
Motley Fool
Mid-Afternoon Market Update: Dow Surges 370 Points; Mirum Pharmaceuticals Shares Drop
December 15, 2020
Toward the end of trading Tuesday, the Dow traded up 1.24% to 30,230.94 while the NASDAQ rose 1% to 12,564.05. The S&P also rose, ...
Tags
LLY
Earnings
BCDA
From
Benzinga
Mid-Day Market Update: Crude Oil Rises 1.5%; Apartment Investment and Management Shares Plunge
December 15, 2020
Midway through trading Tuesday, the Dow traded up 0.38% to 29,974.90 while the NASDAQ rose 0.59% to 12,513.56. The S&P also rose, ...
Tags
Small Cap
NOVA
Markets
From
Benzinga
40 Stocks Moving In Tuesday's Mid-Day Session
December 15, 2020
Gainers Prevail Therapeutics Inc. (NASDAQ: PRVL) shares climbed 83.5% to $22.93 after the company agreed to be acquired by Eli ...
Tags
BDR
CLSN
HJLI
From
Benzinga
Why Mesoblast, Anavex And More Pharma Stocks Are Moving Today
December 15, 2020
Eli Lilly (NYSE: LLY) shares are trading higher on Tuesday after the company announced it will acquire Prevail for total consideration ...
Tags
LLY
Trading Ideas
VTVT
From
Benzinga
Why Plug Power and Prevail Therapeutics Gave the Stock Market a Boost Tuesday Morning
December 15, 2020
Stocks were higher in general as investors remained optimistic about the future.
Tags
PRVL
PLUG
LLY
From
Motley Fool
Why Prevail Therapeutics Stock Is Skyrocketing Today
December 15, 2020
Lilly announced plans to acquire the small biotech.
Tags
Market News
LLY
PRVL
From
Motley Fool
This Gene Therapy Stock Is Ablaze On Eli Lilly's $1.04 Billion Takeover
December 15, 2020
Eli Lilly agreed to buy gene therapy company Prevail Therapeutics for $1.04 billion on Tuesday, sending PRVL stock to a record high. The deal is worth $880 million up front and a CVR.
From
Investor's Business Daily
Eli Lilly Lifts Sales Guidance, Enters Gene Therapy Field With Prevail Acquisition
December 15, 2020
Eli Lilly And Co (NYSE: LLY) announced Tuesday a big-ticket acquisition that would mark its foray into gene therapy research. What ...
Tags
Benzinga
M&A
General
From
Benzinga
Mid-Morning Market Update: Markets Open Higher; Eli Lilly To Acquire Prevail Therapeutics
December 15, 2020
Following the market opening Tuesday, the Dow traded up 0.36% to 29,968.46 while the NASDAQ rose 0.73% to 12,531.15. The S&P also ...
Tags
News
Global
HMY
From
Benzinga
P/E Ratio Insights for Eli Lilly
December 15, 2020
In the current session,Eli Lilly Inc. (NYSE: LLY)is trading at $161.15, after a2.08%gain. Over the ...
Tags
News
P/E Ratio Insights
Benzinga
From
Benzinga
Return On Capital Employed Overview: Eli Lilly
December 15, 2020
Looking at Q3, Eli Lilly (NYSE: LLY) earned $1.28 billion, a 6.81% increase from the preceding quarter. Eli Lilly also posted a total of ...
Tags
News
Earnings
Benzinga
From
Benzinga
Dow Jones Rebounds, Futures Climb On Stimulus Compromise; Baidu Looks Into EVs, Apple To Boost iPhone Output
December 15, 2020
Medtronic and Baidu rallied, Apple led the Dow Jones today on iPhone news as stock futures set up for another strong start on Tuesday.
From
Investor's Business Daily
Stock-index futures point higher as investors monitor stimulus talks
December 15, 2020
Stock-index futures point to a higher start for Wall Street Tuesday, with support tied to continued efforts toward a round of aid spending as COVID-19 cases continue to surge.
Tags
DJIA
ES00
SPX
From
MarketWatch
Eli Lilly Raises Dividend by 15%
December 14, 2020
The company's new payout will be dispensed in March.
Tags
LLY
Market News
From
Motley Fool
Notable ETF Outflow Detected - IWB, PM, LLY, UPS
December 14, 2020
Symbols mentioned in this story: IWB, PM, LLY, UPS Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''...
Tags
ETFs
From
ETF Channel
IPO Stock Madness Moves to Biotech as AbCellera, Certara Soar
December 11, 2020
Hot initial public offerings aren't just for technology companies.
Tags
^DJI
^GSPC
Market News
From
Motley Fool
Why Eli Lilly Stock Jumped Today
December 09, 2020
The company released positive results from a pivotal clinical trial.
Tags
LLY
Market News
From
Motley Fool
Sorrento Therapeutics Cleared to Start Trial for Its Next-Generation Coronavirus Antibody Treatment
December 09, 2020
The new version is more potent, and therefore requires a lower dose.
Tags
SRNE
REGN
LLY
From
Motley Fool
Notable Wednesday Option Activity: AZO, QCOM, LLY
December 09, 2020
Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in AutoZone, Inc. (AZO), where a total volume of 2,910 contracts has been traded thus far...
Tags
Stocks
From
Market News Video
Here's Why A Relief Rally Sent Eli Lilly Stock To A 4-Month High
December 09, 2020
Lilly stock popped Wednesday on investor relief after its newest diabetes treatment, dubbed tirzepatide, succeeded in a Phase 3 test. The drug's safety is in line with others in its class.
From
Investor's Business Daily
The Daily Biotech Pulse: Roche & Moderna Strike COVID Testing Partnership, Rocket Pharma's Gene Therapy Readout, Breast Cancer Presentations
December 09, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
RCUS
BMY
APLS
From
Benzinga
U.S. inches closer to FDA authorization of first COVID-19 vaccine
December 08, 2020
An all-day regulatory meeting scheduled to take place Thursday is the next step toward the likely authorization of the first COVID-19 vaccine in the U.S.
Tags
LLY
GILD
MRNA
From
MarketWatch
How You Can Profit From the Best-Managed Drugmaker on Earth
December 08, 2020
One metric shows that decades of dominance treating diabetes has created unrivaled profitability.
Tags
LLY
SNY
EDIT
From
Motley Fool
Here's Why Biotech Deals Are All the Rage Right Now
December 05, 2020
Pharmaceutical companies are looking to bolster their pipelines.
Tags
BIIB
Market News
MRK
From
Motley Fool
Why BioCryst, Moderna And More Are Moving Today
December 04, 2020
Sutro Biopharma (NASDAQ: STRO) shares are trading higher on Friday after the company announced interim data on its STRO-002 Phase 1 ...
Tags
News
MRNA
Benzinga
From
Benzinga
Is The FDA Still Approving Drugs During the Pandemic?
December 04, 2020
Multiple drugmakers gained FDA approval last week.
Tags
ALNY
LLY
Market News
From
Motley Fool
CDC forecasts up to 19,500 deaths from COVID-19 in week ending Dec. 26
December 04, 2020
The U.S. set yet another record for new cases and fatalities in a single day from the coronavirus illness COVID-19 and the nation’s leading public health agency said there could be up to 19,500 deaths...
Tags
GSK
LUV
AMC
From
MarketWatch
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.